Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KRTAP6-3 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
mRNA | USP49 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | LEPR | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | EPHA6 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | CWC22 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | MAG | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | PEPD | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | CASP8AP2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
mRNA | BTG2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | NATD1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |